Combinations of a full and partial agonist: Experimental evidence of curved isoboles
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F21%3A00547233" target="_blank" >RIV/61388971:_____/21:00547233 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/pii/S0378427421001685?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0378427421001685?via%3Dihub</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.toxlet.2021.06.016" target="_blank" >10.1016/j.toxlet.2021.06.016</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Combinations of a full and partial agonist: Experimental evidence of curved isoboles
Popis výsledku v původním jazyce
Concentration addition as a classic null model for toxicology and pharmacology is based on Loewe's mathematical formulation and the linearity of the isoboles. Novel mathematical models, however, propose curved isoboles in certain conditions. This article aims to test the hypothesis of the curvature of isoboles in experimental measurements. With the assumption of linear isoboles, a partial agonist acts as an antagonist above its maximal effect level. The isoboles automatically convert to a positive slope. For curved isoboles, a partial agonist acts as an antagonist at higher effect levels than its maximal effect alone. The discrepancies between effect levels were studied with an estrogen receptor binding assay (BMAEREluc/ER alpha) using a mixture of 17 beta-estradiol and fulvestrant as a partial agonist. A mixture of 17 beta-estradiol and fulvestrant acts as a partial agonist and causes the diminishing of the effect level of 17 beta-estradiol at a significantly higher level than the maximal effect of their partial-agonistic dose-response curve. Measured, elevated effect levels were well predicted by the mathematical model. Nonlinear isoboles may change our understanding and definition of synergism or antagonism and prompt further attention in receptor theory. (c) 2021 Elsevier B.V. All rights reserved.
Název v anglickém jazyce
Combinations of a full and partial agonist: Experimental evidence of curved isoboles
Popis výsledku anglicky
Concentration addition as a classic null model for toxicology and pharmacology is based on Loewe's mathematical formulation and the linearity of the isoboles. Novel mathematical models, however, propose curved isoboles in certain conditions. This article aims to test the hypothesis of the curvature of isoboles in experimental measurements. With the assumption of linear isoboles, a partial agonist acts as an antagonist above its maximal effect level. The isoboles automatically convert to a positive slope. For curved isoboles, a partial agonist acts as an antagonist at higher effect levels than its maximal effect alone. The discrepancies between effect levels were studied with an estrogen receptor binding assay (BMAEREluc/ER alpha) using a mixture of 17 beta-estradiol and fulvestrant as a partial agonist. A mixture of 17 beta-estradiol and fulvestrant acts as a partial agonist and causes the diminishing of the effect level of 17 beta-estradiol at a significantly higher level than the maximal effect of their partial-agonistic dose-response curve. Measured, elevated effect levels were well predicted by the mathematical model. Nonlinear isoboles may change our understanding and definition of synergism or antagonism and prompt further attention in receptor theory. (c) 2021 Elsevier B.V. All rights reserved.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30108 - Toxicology
Návaznosti výsledku
Projekt
<a href="/cs/project/GJ20-14318Y" target="_blank" >GJ20-14318Y: Individuální a směsná imunotoxicita environmentálních kontaminantů</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Toxicology Letters
ISSN
0378-4274
e-ISSN
1879-3169
Svazek periodika
350
Číslo periodika v rámci svazku
OCT 10 2021
Stát vydavatele periodika
IE - Irsko
Počet stran výsledku
8
Strana od-do
22-29
Kód UT WoS článku
000691222600003
EID výsledku v databázi Scopus
2-s2.0-85109202859